BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 32593708)

  • 21. Development of Small Molecules Targeting the Wnt Signaling Pathway in Cancer Stem Cells for the Treatment of Colorectal Cancer.
    Song L; Li Y; He B; Gong Y
    Clin Colorectal Cancer; 2015 Sep; 14(3):133-45. PubMed ID: 25799881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A perspective on medicinal chemistry approaches towards adenomatous polyposis coli and Wnt signal based colorectal cancer inhibitors.
    Phull MS; Jadav SS; Gundla R; Mainkar PS
    Eur J Med Chem; 2021 Feb; 212():113149. PubMed ID: 33445154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Scutellaria barbata D. Don inhibits colorectal cancer growth via suppression of Wnt/β-catenin signaling pathway.
    Wei LH; Lin JM; Chu JF; Chen HW; Li QY; Peng J
    Chin J Integr Med; 2017 Nov; 23(11):858-863. PubMed ID: 29080197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous destabilization of β-catenin and Ras via targeting of the axin-RGS domain as a potential therapeutic strategy for colorectal cancer.
    Cha PH; Choi KY
    BMB Rep; 2016 Sep; 49(9):455-6. PubMed ID: 27470214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. WNT-pathway components as predictive markers useful for diagnosis, prevention and therapy in inflammatory bowel disease and sporadic colorectal cancer.
    Serafino A; Moroni N; Zonfrillo M; Andreola F; Mercuri L; Nicotera G; Nunziata J; Ricci R; Antinori A; Rasi G; Pierimarchi P
    Oncotarget; 2014 Feb; 5(4):978-92. PubMed ID: 24657851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. B-cell translocation gene 3 overexpression inhibits proliferation and invasion of colorectal cancer SW480 cells via Wnt/β-catenin signaling pathway.
    Mao D; Qiao L; Lu H; Feng Y
    Neoplasma; 2016; 63(5):705-16. PubMed ID: 27468874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MNX1 promotes cell proliferation and activates Wnt/β-catenin signaling in colorectal cancer.
    Yang X; Pan Q; Lu Y; Jiang X; Zhang S; Wu J
    Cell Biol Int; 2019 Apr; 43(4):402-408. PubMed ID: 30614606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/β-catenin signaling pathway.
    Zhang X; Xiong Y; Tang F; Bian Y; Chen Y; Zhang F
    Biomed Pharmacother; 2017 Dec; 96():877-883. PubMed ID: 29145164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of Small-Molecule Inhibitors of the PTK7/β-Catenin Interaction Targeting the Wnt Signaling Pathway in Colorectal Cancer.
    Ganier L; Betzi S; Derviaux C; Roche P; Dessaux C; Muller C; Hoffer L; Morelli X; Borg JP
    ACS Chem Biol; 2022 May; 17(5):1061-1072. PubMed ID: 35483008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RHBDD1 promotes colorectal cancer metastasis through the Wnt signaling pathway and its downstream target ZEB1.
    Zhang M; Miao F; Huang R; Liu W; Zhao Y; Jiao T; Lu Y; Wu F; Wang X; Wang H; Zhao H; Ju H; Miao S; Wang L; Song W
    J Exp Clin Cancer Res; 2018 Feb; 37(1):22. PubMed ID: 29426364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of the Wnt signalling pathway in colorectal tumorigenesis.
    Behrens J
    Biochem Soc Trans; 2005 Aug; 33(Pt 4):672-5. PubMed ID: 16042571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phospholipase D1 Inhibition Linked to Upregulation of ICAT Blocks Colorectal Cancer Growth Hyperactivated by Wnt/β-Catenin and PI3K/Akt Signaling.
    Kang DW; Lee BH; Suh YA; Choi YS; Jang SJ; Kim YM; Choi KY; Min DS
    Clin Cancer Res; 2017 Dec; 23(23):7340-7350. PubMed ID: 28939743
    [No Abstract]   [Full Text] [Related]  

  • 33. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mechanism of Wnt signaling pathway regulation by a truncated mutant of Axin2 in colorectal cancer].
    Wang FW; Wen L; Zhu SW; Yao Q; Cai YM; Ma G
    Ai Zheng; 2007 Oct; 26(10):1041-6. PubMed ID: 17927870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of Wnt/β-catenin signaling regulatory microRNAs in the pathogenesis of colorectal cancer.
    Rahmani F; Avan A; Hashemy SI; Hassanian SM
    J Cell Physiol; 2018 Feb; 233(2):811-817. PubMed ID: 28266708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of Icat induces G(2) arrest and cell death in tumor cell mutants for adenomatous polyposis coli, beta-catenin, or Axin.
    Sekiya T; Nakamura T; Kazuki Y; Oshimura M; Kohu K; Tago K; Ohwada S; Akiyama T
    Cancer Res; 2002 Jun; 62(11):3322-6. PubMed ID: 12036951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic targets in the Wnt signaling pathway: Feasibility of targeting TNIK in colorectal cancer.
    Masuda M; Sawa M; Yamada T
    Pharmacol Ther; 2015 Dec; 156():1-9. PubMed ID: 26542362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of Membranous LRP5 Recycling, Wnt/β-Catenin Signaling, and Colon Carcinogenesis by 15-LOX-1 Peroxidation of Linoleic Acid in PI3P.
    Liu F; Zuo X; Liu Y; Deguchi Y; Moussalli MJ; Chen W; Yang P; Wei B; Tan L; Lorenzi PL; Gao S; Jaoude JC; Mehdizadeh A; Valentin LA; Wei D; Shureiqi I
    Cell Rep; 2020 Aug; 32(7):108049. PubMed ID: 32814052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of the wnt signalling pathway molecules APC, beta-catenin and E-cadherin in colorectal cancer: a tissue microarray-based analysis.
    Lugli A; Zlobec I; Minoo P; Baker K; Tornillo L; Terracciano L; Jass JR
    Histopathology; 2007 Mar; 50(4):453-64. PubMed ID: 17448021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. (Pro)renin receptor promotes colorectal cancer through the Wnt/beta-catenin signalling pathway despite constitutive pathway component mutations.
    Wang J; Shibayama Y; Zhang A; Ohsaki H; Asano E; Suzuki Y; Kushida Y; Kobara H; Masaki T; Wang Z; Nishiyama A
    Br J Cancer; 2019 Jan; 120(2):229-237. PubMed ID: 30555158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.